StockData
Veru Inc. logo

Veru Inc. (VERU) stock

VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 6/30
$2.14+0.06 (+2.88%)

Close on Nov 17, 2026Market cap $36.49MP/E –Yield –

Veru enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Veru's enterprise value was $12.61M on Nov 11, 2026, against $20.54M a year earlier. Over the last 5 years it ranged from $2.48M to $1.23B, with a median of $81.41M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$12.61M-19.0%
2025Dec 31, 2025$15.56M-77.9%
2024Dec 31, 2024$70.31M+24.5%
2023Dec 29, 2023$56.46M-86.7%
2022Dec 30, 2022$425.09M-9.8%
2021Dec 31, 2021$471.02M-22.1%
2020Dec 31, 2020$604.32M+177.4%
2019Dec 31, 2019$217.88M+189.0%
2018Dec 31, 2018$75.39M+31.4%
2017Dec 29, 2017$57.38M+138.2%
2016Dec 30, 2016$24.09M-36.5%
2015Dec 31, 2015$37.96M-64.5%
2014Dec 31, 2014$107.00M-54.4%
2013Dec 31, 2013$234.86M+17.4%
2012Dec 31, 2012$199.99M+65.5%
2011Dec 30, 2011$120.83M-21.2%
2010Dec 31, 2010$153.32M+19.1%
2009Dec 31, 2009$128.72M–

More Veru figures

See a number that looks wrong?